share_log

Chemomab Therapeutics | F-3/A: Registration statement for specified transactions by certain foreign private issuers (Amendment)

SEC announcement ·  Oct 30, 2023 08:33
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more